x

Search for a clinical trial

* (*) mandatory field

PARCT: Phase II Trial of Atezolizumab (Anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides/Sezary Syndrome Patients Relapsed/Refractory After a Previous Systemic Treatment - AT

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Eortc
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - AT
  • ADDRESS: NOT PROVIDED - AT
  • AUSTRIA
  • More information
  • Phone  : -
  • Fax  : -
  • Sponsor of clinical trial

  • EORTC
  • European Organisation for the Research and Treatment of Cancer
  • EORTC
  • Avenue Mounierlaan 83/11
  • 1200 BRUSSELS
  • BELGIUM
  • More information
  • Phone  : 0032 2 7741611
  • Fax  : 0032 2 7723545
  • Website
Last update: August 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.